Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2019, Article ID 5080798, 15 pages
https://doi.org/10.1155/2019/5080798
Research Article

Melatonin and Docosahexaenoic Acid Decrease Proliferation of PNT1A Prostate Benign Cells via Modulation of Mitochondrial Bioenergetics and ROS Production

1Institute of Biology, State University of Campinas, Campinas, SP, Brazil
2Department of Histology, Institute of Biomedical Sciences, Federal University of Uberlândia, Uberlândia, MG, Brazil
3Department of Biology, Institute of Biosciences, Humanities and Exact Sciences, São Paulo State University, São José do Rio Preto, SP, Brazil
4Department of Biochemistry and Tissue Biology, Institute of Biology, State University of Campinas, Campinas, SP, Brazil

Correspondence should be addressed to Rejane M. Góes; rb.psenu.eclibi@seogamer

Received 12 June 2018; Revised 20 July 2018; Accepted 18 September 2018; Published 9 January 2019

Academic Editor: Ana Cipak Gasparovic

Copyright © 2019 Guilherme H. Tamarindo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. D. Oberley, W. Zhong, L. I. Szweda, and L. W. Oberley, “Localization of antioxidant enzymes and oxidative damage products in normal and malignant prostate epithelium,” The Prostate, vol. 44, no. 2, pp. 144–155, 2000. View at Publisher · View at Google Scholar
  2. O. Yossepowitch, I. Pinchuk, U. Gur, A. Neumann, D. Lichtenberg, and J. Baniel, “Advanced but not localized prostate cancer is associated with increased oxidative stress,” The Journal of Urology, vol. 178, no. 4, pp. 1238–1244, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. P. E. Porporato, N. Filigheddu, J. M. B. S. Pedro, G. Kroemer, and L. Galluzzi, “Mitochondrial metabolism and cancer,” Cell Research, vol. 28, no. 3, pp. 265–280, 2017. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Panov and Z. Orynbayeva, “Bioenergetic and antiapoptotic properties of mitochondria from cultured human prostate cancer cell lines PC-3, DU145 and LNCaP,” PLoS One, vol. 8, no. 8, article e72078, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. J. V. Philley, A. Kannan, W. Qin et al., “Complex-I alteration and enhanced mitochondrial fusion are associated with prostate cancer progression,” Journal of Cellular Physiology, vol. 231, no. 6, pp. 1364–1374, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Acuna-Castroviejo, M. Martin, M. Macias et al., “Melatonin, mitochondria, and cellular bioenergetics,” Journal of Pineal Research, vol. 30, no. 2, pp. 65–74, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Martín, M. Macías, J. León, G. Escames, H. Khaldy, and D. Acuña-Castroviejo, “Melatonin increases the activity of the oxidative phosphorylation enzymes and the production of ATP in rat brain and liver mitochondria,” International Journal of Biochemistry and Cell Biology, vol. 34, no. 4, pp. 348–357, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. L. G. A. Chuffa, L. A. Lupi Júnior, F. R. F. Seiva et al., “Quantitative proteomic profiling reveals that diverse metabolic pathways are influenced by melatonin in an in vivo model of ovarian carcinoma,” Journal of Proteome Research, vol. 15, no. 10, pp. 3872–3882, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Castillo, V. Salazar, C. Ariznavarreta, E. Vara, and J. A. F. Tresguerres, “Effect of melatonin administration on parameters related to oxidative damage in hepatocytes isolated from old Wistar rats,” Journal of Pineal Research, vol. 38, no. 4, pp. 240–246, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. A. López, J. A. García, G. Escames et al., “Melatonin protects the mitochondria from oxidative damage reducing oxygen consumption, membrane potential, and superoxide anion production,” Journal of Pineal Research, vol. 46, no. 2, pp. 188–198, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Y. W. Shiu, “Towards rational and evidence-based use of melatonin in prostate cancer prevention and treatment,” Journal of Pineal Research, vol. 43, no. 1, pp. 1–9, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Bartsch, H. Bartsch, A. Schmidt, S. Ilg, K. H. Bichler, and S. H. Flüchter, “Melatonin and 6-sulfatoxymelatonin circadian rhythms in serum and urine of primary prostate cancer patients: evidence for reduced pineal activity and relevance of urinary determinations,” Clinica Chimica Acta, vol. 209, no. 3, pp. 153–167, 1992. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Iguchi, K.-I. Kato, and H. Ibayashi, “Age-dependent reduction in serum melatonin concentrations in healthy human subjects,” Journal of Clinical Endocrinology and Metabolism, vol. 55, no. 1, pp. 27–29, 1982. View at Publisher · View at Google Scholar · View at Scopus
  14. R. S. Sohal and R. Weindruch, “Oxidative stress, caloric restriction, and aging,” Science, vol. 273, no. 5271, pp. 59–63, 1996. View at Publisher · View at Google Scholar · View at Scopus
  15. F. Scialò, D. J. Fernández-Ayala, and A. Sanz, “Role of mitochondrial reverse electron transport in ROS signaling: potential roles in health and disease,” Frontiers in Physiology, vol. 8, no. 428, pp. 1–7, 2017. View at Publisher · View at Google Scholar · View at Scopus
  16. W. A. Sakr, G. P. Haas, B. F. Cassin, J. E. Pontes, and J. D. Crissman, “The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients,” The Journal of Urology, vol. 150, no. 2, pp. 379–385, 1993. View at Publisher · View at Google Scholar · View at Scopus
  17. Y.-X. Lu, D.-L. Chen, D.-S. Wang et al., “Melatonin enhances sensitivity to fluorouracil in oesophageal squamous cell carcinoma through inhibition of Erk and Akt pathway,” Cell Death & Disease, vol. 7, no. 10, pp. e2432–e2412, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Shin, K. Jing, S. Jeong et al., “The omega-3 polyunsaturated fatty acid DHA induces simultaneous apoptosis and autophagy via mitochondrial ROS-mediated Akt-mTOR signaling in prostate cancer cells expressing mutant p53,” BioMed Research International, vol. 2013, Article ID 538529, 11 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Hou, K. Lian, M. Yao et al., “Reduction of n-3 PUFAs, specifically DHA and EPA, and enhancement of peroxisomal beta-oxidation in type 2 diabetic rat heart,” Cardiovascular Diabetology, vol. 11, no. 1, p. 126, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. A. M. Lyberg and P. Adlerceutz, “Monitoring monohydroperoxides in docosahexaenoic acid using high-performance liquid chromatography,” Lipids, vol. 41, no. 1, pp. 67–76, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Esterbauer, R. J. Schaur, and H. Zollner, “Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes,” Free Radical Biology & Medicine, vol. 11, no. 1, pp. 81–128, 1991. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Kirby, C. Hirst, and E. D. Crawford, “Characterising the castration-resistant prostate cancer population: a systematic review,” International Journal of Clinical Practice, vol. 65, no. 11, pp. 1180–1192, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Cui, X. Li, Y. du et al., “Chemoprevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia (HGPIN): a systematic review and adjusted indirect treatment comparison,” Oncotarget, vol. 8, no. 22, pp. 36674–36684, 2017. View at Publisher · View at Google Scholar
  24. D. Cunningham and Z. You, “In vitro and in vivo model systems used in prostate cancer research,” Journal of Biological Methods, vol. 2, no. 1, pp. 17–28, 2015. View at Publisher · View at Google Scholar
  25. H. Meng, Y. Shen, J. Shen, F. Zhou, S. Shen, and U. N. Das, “Effect of n-3 and n-6 unsaturated fatty acids on prostate cancer (PC-3) and prostate epithelial (RWPE-1) cells in vitro,” Lipids in Health and Disease, vol. 12, no. 1, p. 160, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Hevia, J. C. Mayo, I. Quiros, C. Gomez-Cordoves, and R. M. Sainz, “Monitoring intracellular melatonin levels in human prostate normal and cancer cells by HPLC,” Analytical and Bioanalytical Chemistry, vol. 397, no. 3, pp. 1235–1244, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. R. J. Reiter, D. X. Tan, and M. D. Maldonado, “Melatonin as an antioxidant: physiology versus pharmacology,” Journal of Pineal Research, vol. 39, no. 2, pp. 215-216, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. M. H. Barros, B. Bandy, E. B. Tahara, and A. J. Kowaltowski, “Higher respiratory activity decreases mitochondrial reactive oxygen release and increases life span in Saccharomyces cerevisiae,” Journal of Biological Chemistry, vol. 279, no. 48, pp. 49883–49888, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. R. K. Dagda, S. J. Cherra III, S. M. Kulich, A. Tandon, D. Park, and C. T. Chu, “Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission,” Journal of Biological Chemistry, vol. 284, no. 20, pp. 13843–13855, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. M. J. Holden and H. Sze, “Effects of Helminthosporium maydis race t toxin on electron transport in susceptible corn mitochondria and prevention of toxin actions by dicyclohexylcarbodiimide,” Plant Physiology, vol. 91, no. 4, pp. 1296–1302, 1989. View at Publisher · View at Google Scholar
  31. T. M. Silva, E. F. Peloso, S. C. Vitor, L. H. G. Ribeiro, and F. R. Gadelha, “O2 consumption rates along the growth curve: new insights into Trypanosoma cruzi mitochondrial respiratory chain,” Journal of Bioenergetics and Biomembranes, vol. 43, no. 4, pp. 409–417, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. P. K. Vayalil and A. Landar, “Mitochondrial oncobioenergetic index: a potential biomarker to predict progression from indolent to aggressive prostate cancer,” Oncotarget, vol. 6, no. 40, pp. 43065–43080, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Degeorges, F. Hoffschir, O. Cussenot et al., “Recurrent cytogenetic alterations of prostate carcinoma and amplification of c-myc or epidermal growth factor receptor in subclones of immortalized PNT1 human prostate epithelial cell line,” International Journal of Cancer, vol. 62, no. 6, pp. 724–731, 1995. View at Publisher · View at Google Scholar · View at Scopus
  34. W. Friedrichs, S. B. Ruparel, R. A. Marciniak, and L. deGraffenried, “Omega-3 fatty acid inhibition of prostate cancer progression to hormone independence is associated with suppression of mTOR signaling and androgen receptor expression,” Nutrition and Cancer, vol. 63, no. 5, pp. 771–777, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. K. Oono, K. Takahashi, S. Sukehara et al., “Inhibition of PC3 human prostate cancer cell proliferation, invasion and migration by eicosapentaenoic acid and docosahexaenoic acid,” Molecular and Clinical Oncology, vol. 7, no. 2, pp. 217–220, 2017. View at Publisher · View at Google Scholar
  36. M. G. Vander Heiden, L. C. Cantley, and C. B. Thompson, “Understanding the Warburg effect: the metabolic requirements of cell proliferation,” Science, vol. 324, no. 5930, pp. 1029–1033, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. E. Eidelman, J. Twum-Ampofo, J. Ansari, and M. M. Siddiqui, “The metabolic phenotype of prostate cancer,” Frontiers in Oncology, vol. 7, pp. 1–6, 2017. View at Publisher · View at Google Scholar · View at Scopus
  38. I. Valença, N. Pértega-Gomes, J. R. Vizcaino et al., “Localization of MCT2 at peroxisomes is associated with malignant transformation in prostate cancer,” Journal of Cellular and Molecular Medicine, vol. 19, no. 4, pp. 723–733, 2015. View at Publisher · View at Google Scholar · View at Scopus
  39. V. Choudhary, I. Kaddour-Djebbar, V. Lakshmikanthan et al., “Novel role of androgens in mitochondrial fission and apoptosis,” Molecular Cancer Research, vol. 9, no. 8, pp. 1067–1077, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. H. Rottenberg, R. Covian, and B. L. Trumpower, “Membrane potential greatly enhances superoxide generation by the cytochromebc1 complex reconstituted into phospholipid vesicles,” Journal of Biological Chemistry, vol. 284, no. 29, pp. 19203–19210, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Banerjee, N. Aykin-Burns, K. J. Krager et al., “Loss of C/EBPδ enhances IR-induced cell death by promoting oxidative stress and mitochondrial dysfunction,” Free Radical Biology & Medicine, vol. 99, pp. 296–307, 2016. View at Publisher · View at Google Scholar · View at Scopus
  42. R. J. Youle and A. M. van der Bliek, “Mitochondrial fission, fusion, and stress,” Science, vol. 337, no. 6098, pp. 1062–1065, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. Y. Zhang, L. Jiang, W. Hu, Q. Zheng, and W. Xiang, “Mitochondrial dysfunction during in vitro hepatocyte steatosis is reversed by omega-3 fatty acid–induced up-regulation of mitofusin 2,” Metabolism: Clinical and Experimental, vol. 60, no. 6, pp. 767–775, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. B. K. Chacko, P. A. Kramer, S. Ravi et al., “The bioenergetic health index: a new concept in mitochondrial translational research,” Clinical Science, vol. 127, no. 6, pp. 367–373, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. D. X. Tan, L. C. Manchester, M. P. Terron, L. J. Flores, and R. J. Reiter, “One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species?” Journal of Pineal Research, vol. 42, no. 1, pp. 28–42, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. C. Tomás-Zapico and A. Coto-Montes, “A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes,” Journal of Pineal Research, vol. 39, no. 2, pp. 99–104, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Martin, M. Macias, G. Escames et al., “Melatonin-induced increased activity of the respiratory chain complexes I and IV can prevent mitochondrial damage induced by ruthenium red in vivo,” Journal of Pineal Research, vol. 28, no. 4, pp. 242–248, 2000. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Jimenéz-Aranda, G. Fernández-Vázquez, M. Mohammad A-Serrano, R. J. Reiter, and A. Agil, “Melatonin improves mitochondrial function in inguinal white adipose tissue of Zücker diabetic fatty rats,” Journal of Pineal Research, vol. 57, no. 1, pp. 103–109, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. K. Kluckova, A. Bezawork-Geleta, J. Rohlena, L. Dong, and J. Neuzil, “Mitochondrial complex II, a novel target for anti-cancer agents,” Biochimica et Biophysica Acta-Bioenergetics, vol. 1827, no. 5, pp. 552–564, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Bezawork-Geleta, J. Rohlena, L. Dong, K. Pacak, and J. Neuzil, “Mitochondrial complex II: at the crossroads,” Trends in Biochemical Sciences, vol. 42, no. 4, pp. 312–325, 2017. View at Publisher · View at Google Scholar · View at Scopus
  51. M. G. Gobbo, N. Dizeyi, P. A. Abrahamsson et al., “Influence of melatonin on the proliferative and apoptotic responses of the prostate under normal and hyperglycemic conditions,” Journal of Diabetes Research, vol. 2015, Article ID 538529, 18 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  52. M. V. Zamaraeva, R. Z. Sabirov, E. Maeno, Y. Ando-Akatsuka, S. V. Bessonova, and Y. Okada, “Cells die with increased cytosolic ATP during apoptosis: a bioluminescence study with intracellular luciferase,” Cell Death and Differentiation, vol. 12, no. 11, pp. 1390–1397, 2005. View at Publisher · View at Google Scholar · View at Scopus
  53. Z. Yang, Y. Liu, C. Shi et al., “Suppression of PTEN/AKT signaling decreases the expression of TUBB3 and TOP2A with subsequent inhibition of cell growth and induction of apoptosis in human breast cancer MCF-7 cells via ATP and caspase-3 signaling pathways,” Oncology Reports, vol. 37, no. 2, pp. 1011–1019, 2017. View at Publisher · View at Google Scholar · View at Scopus
  54. Y. Zhang, K. Chin-Quee, R. C. Riddle, Z. Li, Z. Zhou, and H. J. Donahue, “BRMS1 sensitizes breast cancer cells to ATP-induced growth suppression,” BioResearch Open Access, vol. 2, no. 2, pp. 77–83, 2013. View at Publisher · View at Google Scholar · View at Scopus
  55. Y. Mebratu and Y. Tesfaigzi, “How ERK1/2 activation controls cell proliferation and cell death is subcellular localization the answer?” Cell Cycle, vol. 8, no. 8, pp. 1168–1175, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. K.-H. Yan, C.-J. Yao, C.-H. Hsiao et al., “Mefloquine exerts anticancer activity in prostate cancer cells via ROS-mediated modulation of AKT, ERK, JNK and AMPK signaling,” Oncology Letters, vol. 5, no. 5, pp. 1541–5, 2013. View at Publisher · View at Google Scholar · View at Scopus
  57. S. Cagnol and J. C. Chambard, “ERK and cell death: mechanisms of ERK-induced cell death - apoptosis, autophagy and senescence,” FEBS Journal, vol. 277, no. 1, pp. 2–21, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. Z. Yin, V. N. Ivanov, H. Habelhah, K. Tew, and Z. Ronai, “Glutathione S-transferase p elicits protection against H2O2-induced cell death via coordinated regulation of stress kinases,” Cancer Research, vol. 60, no. 15, pp. 4053–4057, 2000. View at Google Scholar
  59. M. Estrada, A. Espinosa, M. Müller, and E. Jaimovich, “Testosterone stimulates intracellular calcium release and mitogen-activated protein kinases via a G protein-coupled receptor in skeletal muscle cells,” Endocrinology, vol. 144, no. 8, pp. 3586–3597, 2003. View at Publisher · View at Google Scholar · View at Scopus
  60. E. Gilad, E. Pick, H. Matzkin, and N. Zisapel, “Melatonin receptors in benign prostate epithelial cells: evidence for the involvement of cholera and pertussis toxins-sensitive G proteins in their signal transduction pathways,” The Prostate, vol. 35, no. 1, pp. 27–34, 1998. View at Publisher · View at Google Scholar